PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week

DAEJEON, South Korea, Dec. 8, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the developme...

Related Keywords

Australia ,Daejeon ,Taejon Gwangyoksi ,South Korea ,San Francisco ,California ,United States ,Jin San Yoo ,Pharmabcine Inc ,Ir Pr Team ,Youtube ,Linkedin ,Prnewswire Pharmabcine Inc ,Business Development Team ,Healthcare Conference ,One Partnering ,Biotech Showcase ,Tumor Microenvironment ,Clinical Trial Application ,Age Related Macular Degeneration ,